Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gritstone Oncology, Inc. (GRTS)  
$0.75 0.03 (3.59%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 67,990,000
Market Cap: 50.69(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.7031 - $2.9
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gritstone bio is a biotechnology company developing targeted immunotherapies for cancer and infectious disease. Co. discovers, develops, manufactures, and delivers cancer and infectious disease immunotherapy candidates by utilizing both of its vaccine vectors, self-amplifying mRNA and chimpanzee adenovirus. Co.'s oncology programs in clinical stage development are GRANITE, an individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. Co.'s programs in clinical stage development are: CORAL, a second generation COVID-19 vaccine program and an HIV therapeutic/cure vaccine candidate that Co. is collaborating on with Gilead Sciences, Inc.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 12,000
Total Buy Value $0 $0 $0 $22,829
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 74,769 74,769 74,769 74,769
Total Sell Value $55,949 $55,949 $55,949 $55,949
Total People Sold 5 5 5 5
Total Sell Transactions 5 5 5 5
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 75
  Page 2 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Jones Erin Chief Operating Officer   •       –      –    2021-11-01 4/A OE $0.35 $345 D/D 1,000 46,900     -
   Jones Erin See Remarks   •       –      –    2021-11-01 4 AS $11.14 $11,140 D/D (1,000) 20,000 -62%     
   Jones Erin See Remarks   •       –      –    2021-11-01 4 OE $0.35 $345 D/D 1,000 21,000     -
   Jones Erin See Remarks   •       –      –    2021-10-04 4/A AS $10.71 $10,710 D/D (1,000) 45,900     -
   Jones Erin See Remarks   •       –      –    2021-10-04 4/A OE $0.35 $345 D/D 1,000 46,900     -
   Jones Erin See Remarks   •       –      –    2021-10-04 4 AS $10.71 $10,710 D/D (1,000) 20,000 -45%     
   Jones Erin See Remarks   •       –      –    2021-10-04 4 OE $0.35 $345 D/D 1,000 21,000     -
   Jones Erin See Remarks   •       –      –    2021-10-01 4/A AS $10.68 $10,680 D/D (1,000) 45,900     -
   Jones Erin See Remarks   •       –      –    2021-10-01 4/A OE $0.35 $345 D/D 1,000 46,900     -
   Jones Erin See Remarks   •       –      –    2021-10-01 4 AS $10.68 $10,680 D/D (1,000) 20,000 -48%     
   Jones Erin See Remarks   •       –      –    2021-10-01 4 OE $0.35 $345 D/D 1,000 21,000     -
   Jones Erin See Remarks   •       –      –    2021-09-08 4/A AS $11.37 $22,748 D/D (2,000) 45,900     -
   Jones Erin See Remarks   •       –      –    2021-09-08 4/A OE $0.35 $690 D/D 2,000 47,900     -
   Jones Erin See Remarks   •       –      –    2021-09-08 4 AS $11.37 $22,748 D/D (2,000) 20,000 -51%     
   Jones Erin See Remarks   •       –      –    2021-09-08 4 OE $0.35 $690 D/D 2,000 22,000     -
   Woiwode Thomas Director   –       •      –    2021-08-25 4 A $0.00 $0 D/D 128 128     -
   Woiwode Thomas Director   –       •      –    2021-08-25 4 AS $0.00 $0 I/I (458,024) 0 -29%     
   Woiwode Thomas Director   –       •      –    2021-08-25 4 A $0.00 $0 I/I 13,280 6,612     -
   Rousseau Raphael See Remarks   •       –      –    2021-05-27 4 S $9.00 $26,112 D/D (2,900) 0 -10%     
   Rousseau Raphael See Remarks   •       –      –    2021-05-27 4 OE $0.76 $2,201 D/D 2,900 2,900     -
   Yelensky Roman See Remarks   •       –      –    2021-03-08 4/A OE $0.76 $38,500 D/D 50,724 234,672     -
   Yelensky Roman See Remarks   •       –      –    2021-03-08 4 OE $0.76 $38,500 D/D 50,724 183,948     -
   Cho James Chief Accounting OfficerOffice   •       –      –    2021-01-27 3 IO $0.00 $0 D/D 0 33,436 -42%     
   Rousseau Raphael See Remarks   •       –      –    2021-01-20 4 AS $25.07 $250,705 D/D (10,000) 0 -63%     
   Rousseau Raphael See Remarks   •       –      –    2021-01-20 4 OE $0.76 $7,600 D/D 10,000 10,000     -
  75 Records found
  1  2  3   
  Page 2 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us